Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.
Geissler
R G
RG
Bergmann
L
L
Hacker
H
H
Knupp
B
B
Walker
B
B
Hoelzer
D
D
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001921:Brain / Q000000981:diagnostic imaging; D002051:Burkitt Lymphoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D002493:Central Nervous System Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects*; D004569:Electroencephalography / Q000187:drug effects; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007278:Injections, Spinal; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D009367:Neoplasm Staging; D011239:Prednisolone / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000008:administration & dosage
D003561:Cytarabine; D014750:Vincristine; D003907:Dexamethasone; D003520:Cyclophosphamide; D011239:Prednisolone; D007069:Ifosfamide; D008727:Methotrexate